Biopharma Customer Journey: Mapping Key Touchpoints

Biopharma customer journey mapping helps teams understand how stakeholders move from first awareness to ongoing use of a therapy or service. A biopharma customer journey is not only about patients. It also includes clinicians, hospital buyers, patient support teams, and partner organizations.

This guide explains how to map key touchpoints across the biopharma customer journey. It also covers how marketing, sales, medical affairs, and digital channels can coordinate around those touchpoints.

Biopharma marketing agency services can support this mapping work by aligning message strategy, content plans, and measurement across the full journey.

What “customer journey” means in biopharma

Different customers, different goals

In biopharma, “customer” can mean more than one group. Clinical decision makers may focus on evidence and safety. Hospital procurement may focus on contract terms and service delivery. Patient-facing groups may focus on access and support.

Because goals differ, each segment may see different touchpoints and need different information at different times.

Multiple journeys often run at once

A single brand can have several overlapping journeys. For example, a new-to-therapy journey may run in parallel with an ongoing adherence journey.

Mapping should clarify which journey is in scope before listing touchpoints.

Touchpoints are both human and digital

Touchpoints include meetings, calls, and materials shared by reps. They also include websites, congress pages, email follow-ups, and patient support portals.

Good mapping treats both offline and online touchpoints as part of one system.

Step-by-step: how to map key touchpoints

Step 1: Define the journey scope

Start by naming the journey and the main stakeholder group. Common scopes include launch planning, formulary access, HCP education, or patient onboarding after approval.

Then set a time frame that matches the reality of adoption cycles. Some decisions can take months, and some can take longer.

Step 2: Identify stakeholders and roles

List stakeholders that influence decisions. Typical examples include:

• Prescribers (physicians and other qualified clinicians)
• Clinical teams (nurses, pharmacists, care coordinators)
• Medical affairs (scientific exchange and education)
• Access and payer stakeholders (coverage, prior authorization support)
• Hospital buyers (procurement and contracting)
• Patient support (access services and adherence support)
• Partners (distributors, specialty pharmacies, patient advocacy groups)

Step 3: Create a timeline of journey stages

Many biopharma journeys can be described with shared stages. These stages may vary by product and country, but a common pattern includes awareness, consideration, evaluation, access planning, onboarding, and long-term engagement.

Step 4: List touchpoints for each stage

Touchpoints should be specific and observable. For example, “HCP education” is too broad. “Live advisory board briefing with slides and dosing guide” is more actionable.

When teams map touchpoints, they can capture channel type, owner, content type, and timing.

Step 5: Document pain points and decision moments

Pain points are often linked to uncertainty. Clinicians may need evidence summaries. Buyers may need contract clarity. Patient support may need faster coverage checks.

Decision moments are the points where stakeholders act. Examples include choosing a formulary pathway, deciding to initiate a therapy, or confirming an injection schedule.

Step 6: Build a channel and content inventory

Teams should list what already exists. This includes websites, patient brochures, congress materials, speaker programs, email nurture sequences, and support workflows.

This step can reveal gaps, overlaps, and inconsistent messaging across channels.

Step 7: Plan measurement for touchpoint performance

Biopharma metrics may include engagement, follow-up actions, and downstream outcomes such as coverage approvals and time to treatment. Measurement should match each stage.

A touchpoint that works for awareness may not be the same touchpoint that drives treatment initiation.

Core stages of the biopharma customer journey

Awareness and discovery touchpoints

In the awareness stage, the goal is often to help stakeholders learn the therapy exists and understand why it may matter. Touchpoints here tend to focus on credible education and visibility.

Common touchpoints include:

• Scientific publications and congress abstracts
• Press releases and website landing pages
• Digital ads that direct to dosing and evidence content
• Email announcements for new data releases
• Speaker programs and scientific symposia

For digital discovery, a clear website structure and fast access to product information can reduce drop-off. Biopharma website strategy can support these needs through content organization, landing pages, and information architecture.

Biopharma website strategy is one way teams often improve how stakeholders find evidence, patient support steps, and therapy basics.

Consideration and evidence review touchpoints

During consideration, stakeholders compare options and look for fit. Clinicians may ask about safety, eligibility, endpoints, and real-world use.

Touchpoints that can support evidence review include:

• Mechanism-of-action pages and evidence summaries
• Clinical trial results pages and slide decks
• Comparative data discussions in medical education forums
• FAQs for dosing, administration, and monitoring
• Consultative calls or “field medical” sessions

Medical affairs content may carry more weight here than general brand messages. Clear compliance review can also help teams avoid inconsistencies.

Evaluation, decision support, and access readiness

Evaluation often includes practical next steps. Stakeholders may confirm how a therapy will be prescribed, stocked, and reimbursed.

Touchpoints may include:

• Formulary and reimbursement support materials
• Prior authorization guidance checklists
• Specialty pharmacy workflows and contact pathways
• Product support service descriptions for care teams
• Updated site-of-care guidance for hospitals

Teams may also run account planning discussions to align internal goals with local requirements.

Onboarding and patient start touchpoints

Onboarding focuses on getting therapy started safely and on time. Patient support teams often coordinate access steps, documentation, training, and scheduling.

Common onboarding touchpoints include:

• Enrollment forms and eligibility checks
• Training for administration or device use
• Medication delivery coordination through specialty pharmacy partners
• Care coordination calls between patient support and clinics
• Reminder systems for follow-up and refills

This stage benefits from tight handoffs between customer-facing teams. A mapped journey can show where delays happen and where ownership should shift.

Adherence, retention, and ongoing education touchpoints

After initiation, long-term engagement supports outcomes like follow-up visits and continued access. Stakeholders may need ongoing support, reminders, and updated education.

Touchpoints may include:

• Adherence support programs and follow-up calls
• Patient education updates and monitoring guidance
• Clinician newsletters and periodic evidence refreshers
• Reimbursement re-checks and coverage renewal workflows
• Digital portals for support requests and status tracking

Some biopharma organizations also use data from digital channels to trigger timely outreach. This can be part of a broader biopharma digital transformation marketing approach.

Biopharma digital transformation marketing resources can help teams connect channel operations with lifecycle support workflows.

Mapping key touchpoints by function (marketing, sales, medical, access)

Marketing touchpoints and lifecycle content

Marketing often owns awareness and consideration touchpoints. It may also support evaluation through clear content and digital lead-nurture programs.

Marketing touchpoints typically include:

• Web landing pages for indications and eligibility
• Email nurture sequences for clinicians and care teams
• Congress microsites and session follow-up emails
• Patient education content and support program entry points
• Account-based marketing campaigns for priority accounts

For account-based work, biopharma account-based marketing can help teams coordinate outreach across multiple contacts and align messages to account needs.

Biopharma account-based marketing is a useful reference for structuring targeting, content, and touchpoint plans.

Sales touchpoints and territory alignment

Sales teams often influence evaluation and decision support. Touchpoints can be planned using a territory model and local account strategy.

Key sales touchpoints include:

• Detailing visits with indication-specific messaging
• Calls to confirm unmet needs and pathway fit
• Meeting scheduling for evidence reviews and training
• Service introductions to coordinate access steps
• Field support for formulary discussions and next steps

Touchpoint mapping can help sales and marketing avoid overlap in messaging and ensure the right content is used at the right point.

Medical affairs touchpoints and scientific exchange

Medical affairs is often central to evidence-heavy interactions. In a mapped journey, medical affairs touchpoints should be clearly separated from promotional activity, based on local rules and internal policy.

Typical medical affairs touchpoints include:

• Scientific webinars and peer-to-peer discussions
• Advisory boards and speaker support materials
• Medical information request handling
• Publication sharing and congress follow-up
• Clinic case discussions in appropriate formats

When medical affairs touchpoints are mapped, stakeholders can see consistent evidence and a clear escalation path for questions.

Access touchpoints and operational support

Access teams often own the steps needed for coverage and treatment start. These touchpoints may happen in the background, but they strongly shape patient and clinician experiences.

Common access touchpoints include:

• Coverage verification and benefits investigation
• Prior authorization workflows and documentation support
• Appeals support and payer communication coordination
• Specialty pharmacy coordination and delivery timelines
• Patient support program onboarding and status updates

A journey map can highlight where access steps intersect with clinical decision moments.

Customer journey touchpoint examples for biopharma

Example 1: New therapy launch to HCP consideration

A brand team may start with congress visibility and a website that includes evidence summaries. Marketing can then plan follow-up email touchpoints to guide clinicians to dosing and monitoring information.

Medical affairs may host a webinar series focused on study design and safety considerations. Sales can support account-level meetings to discuss eligibility and local pathways.

Example 2: Formulary adoption and access planning

For formulary evaluation, buyers and clinicians often need clear proof and operational clarity. Touchpoints may include account planning meetings, access checklists, and reimbursement guides.

Access teams can coordinate specialty pharmacy workflows so that treatment start steps are ready once formulary access is approved.

Example 3: Patient onboarding after therapy initiation

After a patient is prescribed, patient support can start enrollment and coverage verification. Clinics may need training on device or administration and clear escalation contacts.

Digital tools can support status tracking for requests, while phone support can handle time-sensitive issues.

How to prioritize touchpoints that matter most

Use impact vs. effort thinking

Not every touchpoint needs the same focus. A useful approach is to identify the moments that change outcomes, such as switching from awareness to evidence review or from evaluation to treatment start.

Then teams can prioritize touchpoints that influence those moments while requiring reasonable effort to improve.

Focus on friction and delays

Journey mapping often reveals where stakeholders hesitate or wait. Common friction points include slow access checks, unclear documentation requirements, or inconsistent information across channels.

Fixing friction can improve the experience even when reach is unchanged.

Ensure message consistency across teams

Different functions may use different content versions. Touchpoint mapping helps align approvals, claims language, dosing resources, and patient support steps.

Consistency also helps stakeholders trust information and reduces the need for repeated questions.

Common mistakes when mapping biopharma customer journey touchpoints

Mapping channels without mapping decisions

Listing touchpoints without identifying decision moments can lead to a document that does not guide action. Touchpoints should connect to what stakeholders decide at each stage.

Ignoring compliance review needs

Biopharma content often goes through review processes. Journey maps should include who approves what, and how content updates are managed over time.

Not including handoffs between teams

Many delays come from unclear handoffs. Journey mapping should define responsibilities and escalation paths between marketing, medical affairs, sales, and access.

Using a single journey for every product

Touchpoints vary by indication, setting, and treatment model. A first mapping exercise may start broadly, but refinements are usually needed per product and market.

Digital touchpoints in the biopharma journey (and what to check)

Website and landing pages

Digital experiences often serve as the first “evidence desk.” Websites can also support access readiness through links to patient support and clinician resources.

Checks may include clarity of navigation, availability of evidence summaries, and easy access to dosing and monitoring info.

Email, content syndication, and lead nurture

Email sequences can move stakeholders from awareness to consideration. The mapping should clarify which content supports each stage and how follow-up is timed.

It should also confirm that opt-in, consent, and data handling follow internal and regulatory rules.

Events and congress follow-ups

Conferences create short windows for attention. Touchpoint mapping should connect pre-event planning, in-event capture, and post-event follow-up content.

It can also include how medical affairs and sales coordinate next steps after a meeting.

Patient support portals and status tools

Patient support often benefits from tools that reduce calls for the same status question. Portals or case systems can show request progress and next steps.

Journey mapping can help define what information should be visible and what needs secure handling.

Putting journey maps into operations

Turn the map into a touchpoint plan

A journey map should become a working plan with owners and timing. Teams can define what content will be used at each touchpoint and who is responsible for updates.

For operational teams, adding workflows for access and onboarding can reduce misalignment.

Align internal reporting and governance

Reporting often differs across functions. A unified view can help teams understand how touchpoints contribute across stages.

Governance should cover compliance checks, content refresh cycles, and issue handling when data or guidance changes.

Use iterative improvements

Journey maps can be updated as new evidence, new access requirements, or new digital tools appear. Teams can treat mapping as an ongoing process rather than a one-time project.

Conclusion: building a biopharma journey map that teams can use

Biopharma customer journey mapping works best when it connects touchpoints to real decision moments. It also needs clear roles across marketing, sales, medical affairs, and access operations.

With a stage-by-stage approach and a detailed touchpoint list, teams can find gaps, reduce friction, and improve coordination from discovery through ongoing support.